brahim Omeish is a junior in Kirkland House studying Neuroscience with a secondary in Economics at Harvard College. His academic and professional interests center on the intersection of healthcare, biotechnology, and venture investing, with a focus on how innovation can be translated into scalable, real-world impact. Ibrahim has worked at Cellarity, a Flagship Pioneering portfolio company, where he gained exposure to both the scientific and strategic aspects of therapeutic development. He has also served as a diligence analyst with Harvard Undergraduate Capital Partners and serves as a biotech venture analyst at RA Capital Management, where he evaluates early-stage companies across healthcare and biotechnology.